Company intelligence / Profile preview
Berko İlaç
Ataşehir, Istanbul, Turkeyberkoilac.com.tr ↗
- Ownership
- Private
- Employees
- ~900
- Development stage
- Other
01
Overview
Berko İlaç has a commercial portfolio of over 170 innovative pharmaceutical products and dietary supplements. The company operates a GMP-compliant manufacturing facility with FDA registration for supplementary food products and exports to more than 20 countries. Its R&D center develops approximately 20 new projects annually focused on both acute/chronic disease therapies and patient-friendly formulations such as combined or controlled-release drugs[1][4][5][6].
- Therapeutic areas
- Infectious DiseasesOther
- Modalities
- Small moleculeBiologicDietary supplement
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Berko İlaç.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Berko İlaç.